1.
PET imaging of [11C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
by Varnäs, Katarina
European journal of nuclear medicine and molecular imaging, 2018, Vol.46 (2), p.367-375
2.
EANM procedure guidelines for PET brain imaging using [(18)F]FDG, version 2
by Varrone, Anea
European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (12), p.2103-2110
3.
Dual tracer tau PET imaging reveals different molecular targets for 11C-THK5351 and 11C-PBB3 in the Alzheimer brain
by Chiotis, Konstantinos
European journal of nuclear medicine and molecular imaging, 2018, Vol.45 (9), p.1605-1617
4.
European multicentre database of healthy controls for [123I]FP-CIT SPECT (ENC-DAT): age-related effects, gender differences and evaluation of different methods of analysis
by Varrone, Anea
European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (2), p.213-227
5.
Guidelines to PET measurements of the target occupancy in the brain for drug development
by Takano, Akihiro
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (12), p.2255-2262
6.
Positron emission tomography measurement of brain MAO-B inhibition in patients with Alzheimer’s disease and elderly controls after oral administration of sembragiline
by Sturm, Stefan
European journal of nuclear medicine and molecular imaging, 2016, Vol.44 (3), p.382-391
7.
EANM procedure guidelines for brain neurotransmission SPECT using 123I-labelled dopamine transporter ligands, version 2
by Darcourt, Jacques
European journal of nuclear medicine and molecular imaging, 2009, Vol.37 (2), p.443-450
8.
Advancement in PET quantification using 3D-OP-OSEM point spread function reconstruction with the HRRT
by Varrone, Andrea
European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (10), p.1639-1650
9.
Extrastriatal binding of [¹²³I]FP-CIT in the thalamus and pons: gender and age dependencies assessed in a European multicentre database of healthy controls
by Koch, Walter
European journal of nuclear medicine and molecular imaging, 2014, Vol.41 (10), p.1938-1946
10.
Automatic semi-quantification of [123I]FP-CIT SPECT scans in healthy volunteers using BasGan version 2: results from the ENC-DAT database
by Nobili, Flavio
European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (4), p.565-573
11.
In vivo imaging of the 18-kDa translocator protein (TSPO) with [18F]FEDAA1106 and PET does not show increased binding in Alzheimer’s disease patients
by Varrone, Andrea
European journal of nuclear medicine and molecular imaging, 2013, Vol.40 (6), p.921-931
12.
Positron emission tomography imaging of the 18-kDa translocator protein (TSPO) with [18F]FEMPA in Alzheimer’s disease patients and control subjects
by Varrone, Andrea
European journal of nuclear medicine and molecular imaging, 2014, Vol.42 (3), p.438-446
13.
Reduction in camera-specific variability in [(123)I]FP-CIT SPECT outcome measures by image reconstruction optimized for multisite settings: impact on age-dependence of the specific...
by Buchert, Ralph
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (7), p.1323-1336
14.
EANM procedure guideline for brain perfusion SPECT using 99mTc-labelled radiopharmaceuticals, version 2
by Kapucu, Özlem L
European journal of nuclear medicine and molecular imaging, 2009, Vol.36 (12), p.2093-2102
15.
Implementation of the European multicentre database of healthy controls for [(123)I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian sy...
by Albert, Nathalie L
European journal of nuclear medicine and molecular imaging, 2016, Vol.43 (7), p.1315-1322
16.
The impact of reconstruction method on the quantification of DaTSCAN images
by Dickson, John C
European journal of nuclear medicine and molecular imaging, 2009, Vol.37 (1), p.23-35
17.
Improved mapping and quantification of serotonin transporter availability in the human brainstem with the HRRT
by Schain, Martin
European journal of nuclear medicine and molecular imaging, 2012, Vol.40 (2), p.228-237
18.
EANM procedure guidelines for brain neurotransmission SPECT/PET using dopamine D2 receptor ligands, version 2
by van Laere, Koen
European journal of nuclear medicine and molecular imaging, 2010, Vol.37 (2), p.434-442
19.
Atomoxetine occupies the norepinephrine transporter in a dose-dependent fashion : a PET study in nonhuman primate brain using (S, S)-[18F]FMeNER-D2
by SENECA, Nicholas
Psychopharmacologia, 2006, Vol.188 (1), p.119-127
20.
Biodistribution and radiation dosimetry of the 18 kDa translocator protein (TSPO) radioligand [18F]FEDAA1106: a human whole-body PET study
by Takano, Akihiro
European journal of nuclear medicine and molecular imaging, 2011, Vol.38 (11), p.2058-2065
